Cypralis awarded grant to advance acute pancreatitis drug
UK life sciences firm Cypralis has been awarded new funding by Innovate UK to take forward its work on cyclophilin D inhibitors targeting degenerative diseases.
Read More
Tag: Cypralis
- Exdensur approved in EU for severe asthma and CRSwNP
- Axol Bioscience acquires Newcells Biotech ophthalmology unit
- Nuclera and leadXpro partner to accelerate structure‑based drug design
- Lundbeck reports positive phase 2b results for migraine prevention drug
- European life sciences coalition launched to boost investment ecosystem
